248 related articles for article (PubMed ID: 1977507)
21. [Treatment with antihistaminic preparations].
Bozhkov B
Vutr Boles; 1990; 29(3):1-8. PubMed ID: 1704665
[No Abstract] [Full Text] [Related]
22. Antiallergic effects of H1-receptor antagonists.
Baroody FM; Naclerio RM
Allergy; 2000; 55 Suppl 64():17-27. PubMed ID: 11291777
[TBL] [Abstract][Full Text] [Related]
23. [Recent advances in antihistamine treatment].
Reshef A; Greiff Y
Harefuah; 1993 Aug; 125(3-4):95-100. PubMed ID: 7901130
[No Abstract] [Full Text] [Related]
24. Combined H1 and H2 antihistamine therapy in chronic urticaria.
Monroe EW; Cohen SH; Kalbfleisch J; Schulz CI
Arch Dermatol; 1981 Jul; 117(7):404-7. PubMed ID: 6114712
[TBL] [Abstract][Full Text] [Related]
25. H1- and H2-receptor antagonists prevent histamine release in allergic patients after the administration of midazolam-ketamine. A randomized controlled study.
Kimura K; Adachi M; Kubo K
Inflamm Res; 1999 Mar; 48(3):128-32. PubMed ID: 10219654
[TBL] [Abstract][Full Text] [Related]
26. Retrospective cohort study on combination therapy with the histamine H2-receptor antagonist lafutidine for antihistamine-resistant chronic urticaria.
Ogawa Y; Ichinokawa Y; Hiruma M; Machida Y; Funakushi N; Sadamasa H; Hiruma M
J Dermatolog Treat; 2013 Dec; 24(6):463-5. PubMed ID: 23639034
[TBL] [Abstract][Full Text] [Related]
27. Use of prophylactic combined H1 and H2 antagonists reduces mortality in chymopapain anaphylaxis.
Moss J
Ann Fr Anesth Reanim; 1985; 4(2):221-4. PubMed ID: 2860828
[TBL] [Abstract][Full Text] [Related]
28. Second-generation H1-receptor antagonists.
Simons FE; Simons KJ
Ann Allergy; 1991 Jan; 66(1):5-16, 19. PubMed ID: 1670985
[TBL] [Abstract][Full Text] [Related]
29. Addition of lafutidine can improve disease activity and lead to better quality of life in refractory cholinergic urticaria unresponsive to histamine H1 antagonists.
Hatakeyama M; Fukunaga A; Washio K; Ogura K; Yamada Y; Horikawa T; Nishigori C
J Dermatol Sci; 2016 May; 82(2):137-9. PubMed ID: 26896422
[No Abstract] [Full Text] [Related]
30. Efficacy of leukotriene receptor antagonist with anti-H1 receptor antagonist plus anti-H2 receptor antagonist for treatment of refractory chronic idiopathic urticaria.
Wan KS; Chang YS
J Dermatolog Treat; 2014 Dec; 25(6):459-61. PubMed ID: 24192062
[TBL] [Abstract][Full Text] [Related]
31. The effects of H1 and H2 receptor antagonism on the response of monkey skin to intradermal histamine, reverse-type anaphylaxis, and passive cutaneous anaphylaxis.
Hutchcroft BJ; Moore EG; Orange RP
J Allergy Clin Immunol; 1979 Jun; 63(6):376-82. PubMed ID: 36420
[TBL] [Abstract][Full Text] [Related]
32. [Antihistamines in pediatrics].
Seidenberg J
Monatsschr Kinderheilkd; 1989 Jan; 137(1):54-6. PubMed ID: 2564163
[TBL] [Abstract][Full Text] [Related]
33. Mediator release in local heat urticaria: protection with combined H1 and H2 antagonists.
Irwin RB; Lieberman P; Friedman MM; Kaliner M; Kaplan R; Bale G; Treadwell G; Yoo TJ
J Allergy Clin Immunol; 1985 Jul; 76(1):35-9. PubMed ID: 2861221
[TBL] [Abstract][Full Text] [Related]
34. [Bibliographic review of antihistaminics H2 in the treatment of chronic (or recurrent) idiopathic urticaria].
Gay G; Drouet M; Bonneau JC; Le Sellin J; Sabbah A
Allerg Immunol (Paris); 1988 Dec; 20(10):377-8. PubMed ID: 2905603
[TBL] [Abstract][Full Text] [Related]
35. Pharmacologic therapy for urticaria.
Negro-Alvarez JM; Carreño-Rojo A; Funes-Vera E; García-Cánovas A; Abellán-Alemán AF; Rubio del Barrio R
Allergol Immunopathol (Madr); 1997; 25(1):36-51. PubMed ID: 9111875
[TBL] [Abstract][Full Text] [Related]
36. Radiocontrast reactions.
Lieberman P; Siegle RL; Treadwell G
Clin Rev Allergy; 1986 May; 4(2):229-45. PubMed ID: 2870792
[No Abstract] [Full Text] [Related]
37. Drug therapy for chronic urticaria.
Juhlin L; Landor M
Clin Rev Allergy; 1992; 10(4):349-69. PubMed ID: 1363535
[TBL] [Abstract][Full Text] [Related]
38. H1 and H2 blockade: a prophylactic principle in anaesthesia and surgery against histamine-release responses of any degree of severity: Part II.
Lorenz W; Doenicke A
N Engl Reg Allergy Proc; 1985; 6(2):174-94. PubMed ID: 2442590
[No Abstract] [Full Text] [Related]
39. The effect of H1 and H2 blockade on cutaneous histamine response in man.
Harvey RP; Schocket AL
J Allergy Clin Immunol; 1980 Feb; 65(2):136-9. PubMed ID: 6101337
[TBL] [Abstract][Full Text] [Related]
40. Histamine2-antagonists in allergic disorders.
Heyneman CA
Ann Pharmacother; 1994 Jun; 28(6):742-3. PubMed ID: 7522657
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
